What is the recommended test and treatment for syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Testing and Treatment for Syphilis

The diagnosis of syphilis requires both nontreponemal (RPR or VDRL) and treponemal (FTA-ABS or TP-PA) tests, followed by treatment with parenteral penicillin G as the first-line therapy for all stages of syphilis. 1

Diagnostic Testing Algorithm

Initial Testing

  1. Two-test approach required:

    • Nontreponemal tests: VDRL (Venereal Disease Research Laboratory) or RPR (Rapid Plasma Reagin)
    • Treponemal tests: FTA-ABS (Fluorescent Treponemal Antibody Absorbed) or TP-PA (T. pallidum Particle Agglutination)
  2. Traditional screening sequence:

    • Start with nontreponemal test (VDRL or RPR)
    • If positive, confirm with treponemal test (FTA-ABS or TP-PA)
  3. Reverse screening sequence (increasingly common):

    • Start with automated treponemal test
    • If positive, perform nontreponemal test to assess disease activity
    • If treponemal positive but nontreponemal negative, confirm with a second treponemal test 2

Diagnostic Considerations

  • Darkfield microscopy or direct fluorescent antibody tests of lesion exudate/tissue are definitive methods for diagnosing early syphilis 1
  • Nontreponemal test results should be reported quantitatively (e.g., 1:32)
  • A fourfold change in titer (equivalent to two dilutions) indicates significant difference in disease activity 1
  • False-positive nontreponemal tests can occur with various medical conditions 1
  • Sequential serologic tests should use the same testing method by the same laboratory 1

Special Situations

  • Neurosyphilis diagnosis:

    • No single test can diagnose neurosyphilis
    • Requires combination of reactive serologic tests, CSF abnormalities (cell count, protein), and reactive VDRL-CSF 1
    • CSF leukocyte count >5 WBC/mm³ suggests active neurosyphilis 1
  • HIV co-infection:

    • May cause atypical serologic results (unusually high, low, or fluctuating titers)
    • Consider additional testing (biopsy, direct microscopy) when serologic tests don't match clinical presentation 1

Treatment Protocol

Primary, Secondary, and Early Latent Syphilis (<1 year)

  • First-line: Benzathine penicillin G 2.4 million units IM in a single dose 1

Late Latent Syphilis (>1 year) or Latent Syphilis of Unknown Duration

  • First-line: Benzathine penicillin G 2.4 million units IM weekly for 3 weeks (total 7.2 million units) 1

Neurosyphilis

  • First-line: Aqueous crystalline penicillin G 18-24 million units IV daily, administered as 3-4 million units every 4 hours for 10-14 days 1

Alternative Regimens (for non-pregnant, non-neurosyphilis patients with penicillin allergy)

  • Doxycycline 100 mg orally twice daily for 14 days (primary, secondary, early latent) or 28 days (late latent) 3
  • Tetracycline 500 mg orally four times daily for 14 days (primary, secondary, early latent) or 28 days (late latent) 3

Special Populations

  • Pregnant women: Only penicillin effectively treats maternal infection and prevents congenital syphilis
  • Penicillin allergy in pregnancy or neurosyphilis: Desensitization required before penicillin treatment 3
  • HIV co-infection: Same treatment regimens as HIV-negative patients, but closer follow-up may be needed 1

Post-Treatment Monitoring

  • Quantitative nontreponemal tests should be obtained at treatment initiation
  • Titers should decline fourfold within:
    • 6 months for primary/secondary syphilis
    • 12-24 months for latent/late syphilis 3
  • Clinical and serological evaluation recommended at 6,12, and 24 months after treatment 1

Common Pitfalls to Avoid

  1. Using only one type of test: Single test is insufficient for diagnosis 1
  2. Comparing results from different test types: RPR titers are often slightly higher than VDRL titers 1
  3. Using treponemal tests to monitor treatment response: These tests typically remain positive for life regardless of treatment success 1
  4. Inadequate follow-up: Treatment failure or reinfection can occur; serial monitoring is essential
  5. Jarisch-Herxheimer reaction: Patients should be advised about this potential acute febrile reaction occurring within 24 hours of treatment 1

Proper diagnosis and treatment of syphilis are critical to prevent progression to late-stage disease with potentially irreversible complications affecting multiple organ systems, particularly the cardiovascular and central nervous systems.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Analytical evaluation of nine serological assays for diagnosis of syphilis.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2015

Research

Diagnosis and management of syphilis.

American family physician, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.